Dr. David Holladay has contributed to 3 publications.
32 citations Prostate-specific antigen nadir of 0.5 ng/mL or less defines disease freedom for surgically staged men irradiated for prostate cancer.
Critz, F. A., Levinson, K., Williams, W. H., Holladay, D., Holladay, C., Griffin, V.; Urology. 1997 May.
See more >>
145 citations Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer.
Critz, F. A., Williams, W. H., Benton, J. B., Levinson, A. K., Holladay, C. T., Holladay, D. A.; J Urol. 2000 Apr.
See more >>
Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques.
Critz, F. A., Williams, W. H., Holladay, C. T., Levinson, A. K., Benton, J. B., Holladay, D. A., Schnell, F. J., Maxa, L. S., Shrake, P. D.; Urology. 1999 Dec.
See more >>
Hospitals & Clinics
specialties & services
